Oramed files Form 144 for 93,360 RSU shares

Oramed Pharmaceuticals Inc. submitted a Form 144 concerning Common Stock.

Accepted by SEC EDGAR 07/01/2026 - 11:47 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Oramed Pharmaceuticals Inc. submitted a Form 144 concerning Common Stock. The filing lists 93,360 shares tied to shares issued upon vesting of RSUs on 06/18/2026, notes Nasdaq as the market, and shows an associated date of 07/01/2026.

The filing text states the shares were issued with “No consideration, shares issued upon vesting of RSUs.” The notice appears procedural and lists header values including 449,061.60 and 40,926,081 in the securities section.

Key Figures

Shares listed: 93,360 shares Header numeric value: 449,061.60 Header numeric value: 40,926,081 +2 more

5 metrics

Shares listed 93,360 shares Shares issued upon vesting of RSUs on 06/18/2026

Header numeric value 449,061.60 Value appearing in securities header (as listed in excerpt)

Header numeric value 40,926,081 Value appearing in securities header (as listed in excerpt)

RSU vesting date 06/18/2026 Date shares were issued upon vesting of RSUs

Associated header date 07/01/2026 Date shown in the securities header

Key Terms

RSUs, Common Stock, Form 144, Nasdaq

4 terms

RSUs financial

"Shares issued upon vesting of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Common Stock financial

"Securities To Be Sold Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Nasdaq market

"07/01/2026 | Nasdaq"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Oramed's Form 144 say about the shares (ORMP)?

The filing lists 93,360 shares of Common Stock tied to RSU vesting on 06/18/2026. It records that the shares were issued upon vesting with no consideration, and identifies Nasdaq as the market with a related date of 07/01/2026.

Were the Oramed shares sold or merely issued upon vesting?

The document states the shares were issued upon vesting of RSUs, with no consideration. The Form 144 lists the securities to be sold, but the excerpt records issuance on 06/18/2026 rather than an executed sale price or buyer.

Does the Form 144 disclose proceeds or a sale price for ORMP shares?

No sale price or proceeds are provided in the excerpt. The filing shows numeric header values including 449,061.60, but it does not explicitly label a proceeds figure or price per share in the provided text.

What market and dates are associated with Oramed's Form 144?

The filing identifies Nasdaq as the market, cites an issuance date of 06/18/2026 for RSU vesting, and displays an associated date of 07/01/2026 in the securities header.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001777328
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORAMED PHARMACEUTICALS INC.
SEC File Number	001-35813
Address of Issuer	1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NEW YORK 10036
Phone	646-844-1164
Name of Person for Whose Account the Securities are To Be Sold	Gabay Avraham
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	93360	449061.60	40926081	07/01/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/18/2026	Shares issued upon vesting of RSUs	ORAMED PHARMACEUTICALS INC.			93360	06/18/2026	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b51 trading plan adopted on 03-30-2026.
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Avraham Gabay By: /s/ Yohanan Azriel Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)